Magnetic Resonance - Technology Information Portal Welcome to MRI Technology••


In 2020 your scanner will probably work with a field strength of :

MRI News Service:
Result: Searchterm 'Dotarem' found in 10 news
Result Pages
More Results: Database  (7)  
News Refinements:  Contrast Agents  Devices  Financial  
FDA Approves First Macrocyclic and Ionic Gadolinium-Contrast Agent for MRI
''Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine ...'
Friday, 22 March 2013   by
FDA approves Dotarem, a new magnetic resonance imaging agent
''The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older. Dotarem is a gadolinium-based contrast agent ...'
Wednesday, 20 March 2013   by
2012 third-quarter revenue
''Accelerating sales momentum in third quarter The pace of sales growth in the third quarter (+10%) marked an acceleration from the first part of the year (+2.9%). This performance was driven mainly by Dotarem with sales up 15.8% for the period. ...'
Wednesday, 24 October 2012   by
Guerbet 2011 first-quarter net sales
''Sales in Europe rose 3.2% driven by gains from Dotarem. Other markets grew 30.1%, increasing their share in total Group revenue to 28%, up from 24% in 2010. In the US, the resumption of direct distribution of Lipiodol (Ethiodol) provided a strong and ...'
Wednesday, 27 April 2011   by
2008 net sales(.pdf)
''Dotarem, Guerbet's flagship magnetic resonance imaging (MRI) product, achieved another year of excellent growth in 2008, expanding 28.9% in volume and 23.6% in value. Following this performance, Dotarem is now the European leader in its ...'
Wednesday, 11 February 2009   by
Sales and earnings growth sustained by Dotarem
''Dotarem sales grew 31% fuelling further market share gains in all countries where it is distributed. To expand in the US, Guerbet plans to register the product for this market and will launch clinical studies between now and year-end to this ...'
Tuesday, 2 September 2008   by
Strong Full-Year 2007 Results
''Sales of Dotarem, a product with well-recognized qualities, grew 31% and contributed significantly to an improvement in the Group's margins. To expand into the US market, beginning in 2008 Guerbet launched clinical studies necessary for registration ...'
Wednesday, 12 March 2008   by
Positive full-year trends for fiscal 2007(.pdf)
''Sales growth by flagship products in major markets Sales of Dotarem and Xenetix grew respectively 19.2% and 4% in sales and 24.5% and 9.8% in volume. The unique qualities of Dotarem have given Guerbet a major competitive advantage that should ...'
Tuesday, 11 September 2007   by
2007 first-half sales highlights
''2007 second-quarter sales and outlook Sales grew 7% in Europe confirming the positive trends of the first quarter in the Group’s key markets of France, Germany and Italy. This expansion was driven primarily by the well established advantages of ...'
Thursday, 26 July 2007   by
Sustained sales growth driven by an ambitious program of capital expenditures
''Continued gains by our flagship productsSales of Xenetix and Dotarem, our two strategic high value added products grew respectively5.1% and 8.6%, despite a reduction in prices from the levels of 2005.International expansionIn line with trends ...'
Tuesday, 13 March 2007   by
News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
Remember not only to say the right thing in the right place, but far more difficult still, to leave unsaid the wrong thing at the tempting moment.
- Benjamin Franklin
Share This Page

Forgot your UserID/Password ?  

      Ups uses cookies! By browsing, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2003 - 2018 SoftWays. All rights reserved. [ 19 April 2019]
Terms of Use | Privacy Policy | Advertising
 [last update: 2018-03-08 05:11:00]